SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-059919
Filing Date
2022-03-01
Accepted
2022-03-01 08:16:04
Documents
15
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d313684d8k.htm   iXBRL 8-K 26531
2 EX-5.1 d313684dex51.htm EX-5.1 6581
3 EX-99.1 d313684dex991.htm EX-99.1 53646
7 GRAPHIC g313684dsp001.jpg GRAPHIC 10650
  Complete submission text file 0001193125-22-059919.txt   232216

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA agen-20220301.xsd EX-101.SCH 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20220301_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20220301_pre.xml EX-101.PRE 10816
9 EXTRACTED XBRL INSTANCE DOCUMENT d313684d8k_htm.xml XML 3297
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 22694097
SIC: 2836 Biological Products, (No Diagnostic Substances)